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Signaling through D2 class dopamine receptors is cru-
cial to correct brain development and function, and dys-
function of this system is implicated in major neuro-
logical disorders such as Parkinson’s disease and schizo-
phrenia. To investigate potential novel mechanisms of
D2 receptor regulation, the third cytoplasmic loop of the
D2 dopamine receptor was used to screen a rat hip-
pocampal yeast two-hybrid library. Spinophilin, a re-
cently characterized F-actin and protein phosphatase-1-
binding protein with a single PDZ domain was
identified as a protein that specifically associates with
this region of D2 receptors. A direct interaction between
spinophilin and the D2 receptor was confirmed in vitro
using recombinant fusion proteins. The portion of spi-
nophilin responsible for interacting with the D2 third
cytoplasmic loop was narrowed to a region that does not
include the actin-binding domain, the PDZ domain, or
the coiled-coil. This region is distinct from the site of
interaction with protein phosphatase-1, and both D2 re-
ceptors and protein phosphatase-1 may bind spinophilin
at the same time. The interaction is not mediated via the
unique 29-amino acid insert in D2long; both D2long and
D2short third cytoplasmic loops interact with spinophi-
lin in vitro and in yeast two-hybrid assays. Expression of
D2 receptors containing an extracellular hemagglutinin
epitope in Madin-Darby canine kidney cells results in
co-localization of receptor and endogenous spinophilin
as determined by immunocytochemistry using antibod-
ies directed against spinophilin and the HA tag. We hy-
pothesize that spinophilin is important for establishing
a signaling complex for dopaminergic neurotransmis-
sion through D2 receptors by linking receptors to down-
stream signaling molecules and the actin cytoskeleton.
Dopamine receptors are members of the G protein-coupled
receptor (GPCR)1 superfamily that mediate their actions by
coupling to intracellular signal transduction cascades via het-
erotrimeric G proteins. Five different dopamine receptors have
been described belonging to two classes that are defined based
on structure, function, and pharmacology (1). D2-like receptors,
D2, D3, and D4, couple to G proteins of the Gi/o class and have
diverse downstream effectors, including adenylyl cyclase and G
protein-coupled inward rectifier K1 channels (GIRKs). In con-
trast, D1-like receptors D1 and D5 are coupled to increases in
adenylyl cyclase activity through Gs. D1-like receptors have
short third cytoplasmic loops (i3) and very long carboxyl-ter-
minal cytoplasmic tails. Conversely, D2-like receptors are char-
acterized by long third cytoplasmic loops and short carboxyl-
terminal tails. D2-like receptors are more polymorphic than
D1-like receptors; for example, D2 exists as two isoforms,
D2long and D2short, which differ by 29 amino acids within the
third cytoplasmic loop (2). In many GPCRs the third cytoplas-
mic loop is important for the coupling to G proteins. Typically,
short peptide sequences near the amino and carboxyl termini of
the third loop participate in the coordination of receptor-G
protein interactions (3–5). Thus, the rest of the third cytoplas-
mic loop might then be free to interact with cytosolic or mem-
brane-associated proteins that regulate receptor-mediated sig-
naling cascades (6).
The complexity of signaling pathways and the specificity of
effector action generated by G protein-coupled receptors sug-
gest a higher order organization than is currently known to
exist (7, 8). Regulation of GPCR desensitization and resensiti-
zation through phosphorylation-dependent events mediated by
G protein-coupled receptor kinases and the arrestins have been
worked out for many classes of GPCRs (9). These proteins are
responsible for terminating receptor-mediated signaling follow-
ing ligand binding and receptor activation. Although much
progress has been made to define these pathways, little is
known about the basic organization of G protein-coupled recep-
tors, their effector molecules, and regulators of receptor func-
tion into complexes that affect GPCR-mediated signaling. In
this study we show that the third cytoplasmic loop of D2 do-
pamine receptors binds to spinophilin, a protein phosphatase-1
(PP-1)-binding protein that contains an amino-terminal actin-
binding domain and a single PDZ domain (10) through a novel,
non-PDZ-dependent mechanism. These data and others (10,
11) suggest that spinophilin may be a core member of a signal-
ing complex that links D2 receptors and various downstream
molecules to the actin cytoskeleton within neurons that receive
dopaminergic input.
EXPERIMENTAL PROCEDURES
Construction of Bait Plasmids—cDNA fragments encoding the third
cytoplasmic loop (i3) of D2long (D2L) and D2short (D2S) (Tyr
213–Lys370
and Tyr213–Lys341, respectively) were amplified by PCR using appro-
priate primers containing SalI and NotI restriction sites and rat D2L
and D2S cDNA templates kindly provided by Dr. Marc Caron (Duke
University). These fragments were ligated in frame to the correspond-
ing sites in pPC97 (12), creating plasmids encoding either GAL4BD-
D2Li3 or GAL4BD-D2Si3 fusion proteins.
Yeast Two-hybrid Assays—Two hybrid techniques were performed as
described (Ref. 13; CLONTECH Manual). For screening cDNA libraries,
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the bait vector pPC97.D2Li3 was transformed into yeast strain CG-
1945 (CLONTECH) using a modified lithium acetate protocol (14). After
confirming expression of the bait protein, a rat hippocampal cDNA
library in the vector pPC86 (15) was transformed into the strain har-
boring the bait plasmid, and transformants expressing both the bait
and interacting prey proteins were selected on medium lacking leucine,
tryptophan, and histidine. His1 colonies were then tested for b-galac-
tosidase activity using the filter lift assay. Clones that were consistently
phenotypically His1 and lacZ1 were further characterized. Approxi-
mately 1 3 106 transformants were screened; several different clones
met these criteria. A single clone was chosen for further pursuit based
on its strongly His1/lacZ1 phenotype. Library plasmids were isolated
using the Yeast DNA Isolation system (Stratagene) and amplified in
Escherichia coli. Sequencing was performed by the Automated Se-
quencing Facility (University of North Carolina at Chapel Hill).
Construction of Bacterial Fusion Proteins and in Vitro Binding As-
says—The cDNA fragment encoding spinophilin (amino acids 100–767)
was excised from pPC86.clone7 as a SalI-NotI fragment and subcloned
into pGEX5X2 (Amersham Pharmacia Biotech). This plasmid,
pGEX5X2.spinophilin (100–767), was transformed into E. coli strain
BL21DE3(pLysS) (Novagen), allowing expression of spinophilin as a
glutathione S-transferase (GST) fusion protein. Deletion constructs
were made using a combination of restriction endonuclease digestion
and PCR cloning. Several GST fusion proteins showed a consistent
pattern of lower molecular weight bands in the purified sample. We
believe these are either unstable degradation products or incompletely
translated products. A GST fusion protein encoding amino acids 101–
372 of neurabin (16) was generated by PCR amplification of the corre-
sponding cDNA from rat brain Quick Clone cDNA (CLONTECH) using
the Advantage GC-rich PCR kit (CLONTECH). The cDNA fragment
was subcloned into pGEX5X2 as described above. Bacterial fusion pro-
tein production was induced by addition of 1 mM isopropyl-1-thio-b-D-
galactopyranoside and overnight growth at 30 °C. Fusion protein was
either purified in large batches using glutathione-agarose (Sigma), or
induced bacteria were frozen in small aliquots and fusion protein was
purified at the time of the experiment. To generate a tagged D2L third
cytoplasmic loop fusion, the SalI-NotI fragment encoding D2Li3 was
excised from the bait plasmid and inserted into pET32c (Novagen),
creating pET32c.D2Li3. This plasmid, encoding a fusion protein con-
sisting of thioredoxin, an S tag, a His6 tag and the third cytoplasmic
loop of D2L, was transformed into BL21DE3(pLysS) cells, and protein
production was induced as above. The fusion protein was purified from
the insoluble fraction using Ni21-nitrilotriacetic acid-agarose (Novagen)
after solubilization of inclusion bodies in 6 M urea. Fusion protein was
refolded by step-wise removal of denaturant by dialysis. For binding
assays, GST-spinophilin (100–767) or negative control proteins were
immobilized on GSH-agarose at 4 °C in binding buffer (50 mM sodium
phosphate, pH 7.4, 10% glycerol, 0.05% Triton X-100, 0.1% nonfat dry
milk). His-tagged D2Li3 were incubated with the immobilized GST
fusion proteins or GST alone in 200 ml of binding buffer for 2 h at 4 °C.
Proteins bound to the immobilized resin were collected by centrifuga-
tion, washed extensively in binding buffer 1 150 mM NaCl, eluted in 13
Laemmli sample buffer, and separated by SDS-polyacrylamide gel elec-
trophoresis. Unbound proteins were precipitated with acetone and an-
alyzed separately. Proteins were transferred to Immobilon-P (Millipore)
membranes, and bound (or unbound) tagged D2Li3 was detected by
incubation with S protein-horseradish peroxidase (Novagen; 1:10,000)
for 1 h at room temperature. Membranes were washed 3 times in TTBS
(100 mM Tris, pH 7.4, 150 mM NaCl, 0.05% Tween 20) and developed
using ECL (NEN Life Science Products).
In Vitro Binding with 35S-Labeled Proteins—Binding assays were
done essentially as described above, except that 35S-labeled proteins
were produced using pET28c.D2Li3 as template in coupled in vitro
transcription/translation reactions (TNT system, Promega). This plas-
mid was created by subcloning the SalI-NotI D2Li3 fragment into
pET28c (Novagen), which lacks the thioredoxin and S protein tags and
instead has a short sequence encoding a T7 and a His6 tag.
35S-Labeled
PP-1g1 was synthesized using pGEM-7z-rPP1g1 (Provided by Dr.
Ernest Y. C. Lee, New York Medical College) as template. 5 ml of TNT
reaction product were added directly to the GST fusion protein-coupled
beads in 500 ml of binding buffer. Beads were tumbled for 2 h at 4 °C
and pelleted at 8000 rpm for 20 s, and supernatant was removed. Beads
were washed three times with 1 ml of binding buffer plus 50 mM NaCl
or 500 mM NaCl. Protein was eluted from beads in 13 Laemmli sample
buffer. Proteins in the unbound fractions were precipitated and ana-
lyzed separately (data not shown). Total bound fractions were sepa-
rated on 13.5% polyacrylamide gels. Dried gels were subjected to Phos-
phorImager analysis by exposure overnight followed by scanning on a
Storm 840 PhosphorImager (Molecular Dynamics). All binding assays
were performed multiple times to confirm reliability of the in vitro
interactions.
Antibody Production and Purification—Rabbit polyclonal antibodies
were generated against two different peptides based on the primary
sequence of rat spinophilin. Peptide 1 contains amino acids 114–131
(GTSVSERVSRFNSKPAPS); peptide 2 contains amino acids 367–390
(DNGRAPDMAPEEVDESKKEDFSEA). Peptides were synthesized
and coupled to keyhole limpet hemocyanin at the University of North
Carolina Peptide Synthesis Core Facility. Antibodies were produced
commercially (Covance). Antisera were tested for their ability to recog-
nize the expected 140-kDa protein from lysates of MDCK cells, as well
as the appropriate GST fusion protein, by Western blot. We chose to use
the antibody NC152, directed against peptide 1, because it gave unam-
biguous results by Western blot analysis and had less background than
the antibody against peptide 2 (NC153). Crude serum was purified
using DEAE-Affy-Gel Blue (Bio-Rad) according to the manufacturer’s
instructions, except that serum was diluted 1:5 in application buffer
before applying to column.
Construction of HA-tagged D2S Dopamine Receptor—The tagging of
D2S was based on the scheme developed by Keefer et al. (17) and
Wozniak and Limbird (18). Briefly, PCR was used to generate a 514-
base pair fragment containing a 59 HindIII site, a Kozak sequence, and
nucleotides encoding the HA tag/linker region (YPYDVPDYALV) in-
serted between Asp2 and Pro3 in the D2S protein sequence. The corre-
sponding portion of the wild type receptor cDNA in pRc/RSV-hD2S
(provided by Tony Sandrasagra, Hoechst-Marion Roussel) was excised
and replaced with the HA tag encoding fragment. Recombinant receptor
cDNAs were detected by PCR using a 59 primer specific for the HA tag.
Sequencing confirmed the presence of the HA tag in the correct reading
frame.
Generation of MDCK Cells Expressing HA-D2S—MDCK type II cells
were cultured in Dulbecco’s modified Eagle’s medium/Ham’s F-12 1 5%
fetal calf serum. Cells were transfected with pRc/RSV.HA-hD2S using
Lipofectin (Life Technologies, Inc.) according to the manufacturer’s
instructions. Stable transfectants were selected by culturing in media
containing 400 mg/ml G418. Colonies were subcloned and checked for
expression of HA-D2S by immunofluorescence microscopy using mono-
clonal antibody HA.11 (BabCo). Nonclonal cell lines expressing high
levels of HA-D2S receptor in ;75% of cells were used for immunofluo-
rescence microscopy.
Immunofluorescence Microscopy—MDCK cells expressing HA-D2S
were plated on Transwell filters and grown to confluence (5–7 days).
Cells were fixed in 220 °C methanol for 3 min. After washing with PBS,
cells were blocked in PBS 1 0.2% bovine serum albumin, 4% nonfat dry
milk, 0.1% Triton X-100 for either 4 h at room temperature or overnight
at 4 °C. The cells were then incubated with primary antibodies diluted
to the appropriate concentrations in PBS 1 0.2% bovine serum albumin
overnight at 4 °C. Cells were washed three times for 10 min in PBS 1
0.1% Triton X-100 followed by one wash with PBS. Secondary antibod-
ies were diluted in PBS 1 0.2% bovine serum albumin and applied for
.2 h at room temperature. Cells were washed as above and mounted on
glass slides using a Molwiol 4–88 mounting medium. Images were
captured using a Leica TCS-NT confocal microscope and processed in
Adobe Photoshop 4.0.
RESULTS AND DISCUSSION
In an attempt to isolate D2 dopamine receptor-associated
proteins, we used the yeast two-hybrid system to identify pro-
teins that interact with the third cytoplasmic loop. Screening of
a rat hippocampal cDNA library yielded several potential in-
teractors (His1), one (clone 7) of which was chosen for further
pursuit, based on its moderately strong blue phenotype in the
b-galactosidase assay. The specificity of the interaction in yeast
was tested by retransforming pPC86.clone7 along with the
original bait pPC97.D2Li3, pPC97 alone, or a plasmid encoding
an irrelevant bait back into yeast strain CG-1945. The inter-
action between the receptor loop and the novel protein specif-
ically allowed growth on medium lacking leucine, tryptophan,
and histidine (SC-Leu/Trp/His) (Fig. 1). Neither the bait pro-
tein, GAL4BD-D2Li3, nor the prey protein were able to acti-
vate transcription of the reporter genes in the presence of only
empty prey or bait vectors, respectively (Fig. 1). Digestion of
the library plasmid, pPC86.clone7, with SalI and NotI yielded
an ;2-kilobase pair cDNA fragment (data not shown). Se-
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quencing of this fragment and analysis of the cDNA sequence
using the BLAST programs at the NCBI indicated that the
cDNA insert in pPC86.clone7 encoded amino acids 100–767 of
the recently identified protein spinophilin. Spinophilin was
originally identified in another yeast two-hybrid screen as a
PP-1-interacting protein (10). Subsequently, spinophilin was
also described as an actin-binding protein, based on ability to
bind 125I-labeled actin by blot overlay analysis, and termed
neurabin-II (11). Spinophilin is an 817-amino acid protein that
is expressed in many tissues but enriched in brain and contains
several important structural domains. At the amino terminus,
from amino acids 1–154, is a putative actin-binding domain
(11). The carboxyl-terminal half of the protein contains both a
single PDZ domain and a region predicted to form a coiled-coil
structure (10, 11) (see Fig. 3A). Typically, PDZ domains bind to
specific carboxyl-terminal sequences of the form E(S/T)X(V/
I)COOH, although there are exceptions to this consensus (19). In
recent years this domain has been implicated as a common
protein-protein interaction domain found in proteins that func-
tion as scaffolds for organizing ion channels, receptors, and
cytoplasmic signaling components into macromolecular signal-
ing complexes (see Refs. 19 and 20 for review). This protein was
named spinophilin on the basis of its intense immunoreactivity
in the head and neck of dendritic spines on hippocampal and
striatal neurons. Although spinophilin is most highly concen-
trated in hippocampus, it also expressed at high levels in many
brain regions, including caudate, putamen, and hypothalamus,
with lower levels being expressed in cerebellum and cortex (10).
These brain regions correspond to regions where moderate to
high levels of D2 dopamine receptor expression have been
observed (21–23).
To confirm the interaction between the third cytoplasmic
loop of D2L and spinophilin biochemically, we used an in vitro
binding assay to test for the direct interaction of recombinant
fusion proteins. GST, GST-PAM (unrelated protein), and GST-
spinophilin (100–767) were immobilized on glutathione-aga-
rose beads and incubated with His6-tagged D2Li3. After exten-
sive washing the bound fraction was analyzed by blotting with
horseradish peroxidase-conjugated S protein. We found that
the His6-D2Li3 fusion protein specifically bound the GST-spi-
nophilin (100–767) fusion but not GST or GST-PAM-CD (Fig.
2), confirming our yeast two-hybrid results.
As discussed above, spinophilin has several domains that
suggest specific functions. Spinophilin has been reported to
bind F-actin through an amino-terminal actin-binding domain
(11), as well as PP-1 through an interaction carboxyl-terminal
to amino acid 296 (10). Therefore, we were interested in nar-
rowing the site of interaction between D2Li3 and spinophilin to
a specific region of spinophilin. To do this, a series of GST
fusion proteins with various regions of spinophilin were con-
structed and purified from bacteria (Fig. 3A). 35S-Labeled pro-
teins were incubated with GST fusion proteins, and bound
protein complexes were isolated, washed, separated by electro-
phoresis, and analyzed by PhosphorImager analysis. Binding
of labeled D2L third cytoplasmic loop to spinophilin only oc-
curred with GST-spinophilin fusion proteins containing the
region encompassed by amino acids 100–371 (Fig. 3B, lanes 2,
3, and 6). The site of interaction between spinophilin and D2L
dopamine receptors occurs within the unique region distal to
the actin-binding domain but upstream of the both the PDZ
domain and the coiled-coil. Interestingly, the interaction occurs
independently of the PDZ domain, suggesting that spinophilin
links D2 receptors to other membrane-anchored proteins that
contain carboxyl-terminal PDZ ligand sequences.
Spinophilin is also known to associate with protein phospha-
tase-1. PP-1 is a ubiquitously expressed protein phosphatase;
its activity is regulated in different tissues by tissue-specific
binding proteins (24). In the nervous system, cells that receive
dopaminergic input contain DARPP-32 (dopamine and cAMP
regulated phosphoprotein, Mr 5 32,000), which, when phospho-
rylated in response to elevations in cAMP and protein kinase A
activity mediated by D1 receptor activation, is a potent inhib-
itor of PP-1 activity. Recent data show that D2-selective ago-
nists negatively regulate phosphorylation of DARPP-32 (25). In
the initial description of spinophilin, the site of interaction with
PP-1 was not mapped (10). Several groups have reported con-
sensus motifs for anchoring/targeting protein interactions with
PP-1 (26, 27); spinophilin contains such a motif between amino
acids 447–451 (R-K-I-H-F-S). We tested whether this site could
mediate the interaction with PP-1 by incubating 35S-labeled
PP-1g1 with the various GST-spinophilin fusion proteins as
above. Fig. 3C shows that PP-1g1 bound specifically to all
GST-spinophilin fusion proteins containing the putative PP-1
FIG. 1. The third cytoplasmic loop of D2L (D2Li3) interacts
with spinophilin in the yeast two-hybrid system. Yeast strain
CG-1945 was co-transformed with plasmids encoding fusions to either
the GAL4 DNA-binding domain (Bait) or the GAL4 activation domain
(Prey). The ability of two proteins to interact was tested by growing the
yeast on selective medium (SC-Leu/Trp/His). The interaction between
D2Li3 and spinophilin is specific; the receptor loop does not interact
with control proteins. Spinophilin, too, is unable to activate transcrip-
tion of the reporter gene in the absence of D2Li3. To the right is
indicated the relative strength of the interaction as determined by
visual inspection of b-galactosidase (b-gal) filter lift assays. 111, very
strong; 11, moderate; 1, weak; 2, negative; NT, not tested.
FIG. 2. Spinophilin binds to the third cytoplasmic loop of D2L
in vitro. The region of spinophilin (amino acids 100–767) isolated in
the two-hybrid screen was expressed as a bacterial GST fusion protein
and immobilized on glutathione-agarose beads. The third cytoplasmic
loop of D2L was also expressed and purified from bacteria as a hexa-
histidine-tagged protein. Different concentrations of the His6- D2Li3
fusion protein were incubated with either immobilized GST alone (lanes
1 and 4), GST-PAM-CD (as a negative control) (lanes 2 and 5), or
GST-spinophilin (100–767) (lanes 3 and 6). Bound proteins were ana-
lyzed by SDS-polyacrylamide gel electrophoresis and blot overlay anal-
ysis with horseradish peroxidase-conjugated S protein, which recog-
nizes a short peptide sequence in the tagged D2Li3 fusion protein.
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interaction site. Blot overlay assays with purified, digoxygenin-
labeled PP-1 confirm that these three GST fusion proteins
alone are able to bind PP-1.2 Binding of PP-1 was lost when
spinophilin was truncated to delete this motif (Fig. 3C, lane 3,
GST-spinophilin (100–371)). Interestingly, the same fragment
was still able to bind to the third cytoplasmic loop of D2L (Fig.
3B). These data indicate that D2 dopamine receptors bind to
spinophilin through a distinct region upstream of the PP-1-
binding site (Fig. 3). Furthermore, we tested whether D2Li3
and PP-1 could associate with spinophilin at the same time.
Both radiolabeled proteins were able to bind GST-spinophilin
when tested in the same reaction (Fig. 3D). Although this
result does not prove that the D2 third cytoplasmic loop and
PP-1 interact with the same spinophilin molecule, it is consist-
ent with the characterization of spinophilin as a linker protein
that brings intracellular signaling molecules (PP-1) into close
proximity of a membrane bound receptor (D2).
Our data suggest that the interaction between the third
cytoplasmic loop of D2 receptors and spinophilin occurs within
the amino-terminal part of the region in spinophilin bridging
the actin-binding domain and the PDZ domain. This segment is
not well conserved among known proteins. In fact, spinophilin
is similar to only one other protein, neurabin, in overall struc-
tural organization and primary sequence (11, 16).
Alignment of the corresponding regions of spinophilin (100–
371) and neurabin (101–372) reveals limited sequence identity,
and ;35% sequence similarity (Fig. 4A). We were therefore
interested in whether both spinophilin and neurabin could bind
to the D2Li3 loop. The regions of spinophilin and neurabin
above were produced as GST fusion proteins and assayed for
binding to 35S-labeled D2Li3 loop. GST-spinophilin (101–370)
specifically bound to the D2 third cytoplasmic loop (Fig. 4B,
lane 2), whereas the corresponding region of neurabin did not
bind to the receptor loop (Fig. 4B, lane 3). These data suggest
that neurabin and spinophilin may serve distinct functions in
vivo and furthers the suggestion of overlapping but distinct
sets of binding partners. However, we have not tested other
domains in neurabin and cannot rule out that another site in
neurabin is responsible for binding the third cytoplasmic loop
of D2 (or possibly other GPCRs).
The functional significance of the two splice variants of D2 is
still not understood. We therefore tested whether or not the
interaction with spinophilin is specific for D2L versus D2S
using both the yeast two-hybrid system and in vitro binding2 R. Terry and S. Shenolikar, personal communication.
FIG. 3. Mapping the interactions between spinophilin, D2 receptors, and PP-1. A series of GST fusion proteins shown schematically (A,
right) were expressed and purified from bacteria as shown in the Coomassie-stained gel (A, left). The fusions proteins are as follows: lane 1, GST
alone; lane 2, GST-spinophilin (100–767) (two-hybrid clone, as marked by arrowheads); lane 3, GST-spinophilin (100–371); lane 4, GST-spinophilin
(354–494); lane 5, GST-spinophilin (488–593); lane 6, GST-spinophilin (100–543). B, 5 ml of in vitro translated 35S-labeled His6-D2Li3 were
incubated with each GST fusion protein immobilized on beads. Bound proteins were visualized by SDS-polyacrylamide gel electrophoresis and a
PhosphorImager analysis. One-half the input to each reaction was analyzed (In). The recombinant D2L third cytoplasmic loop bound specifically
to GST-spinophilin fusion proteins containing amino acids 100–371. C, because spinophilin is known to bind PP-1, we tested where this binding
occurs using the set of GST-spinophilin fusion proteins and in vitro translated PP-1g1. PP-1 binds to spinophilin in the region between amino acids
371–488, at a site distinct from the D2Li3-binding site, because GST-spinophilin (100–371) can still bind D2Li3 but not PP-1, and GST-spinophilin
(354–494) can bind PP-1 but not D2Li3. Therefore, D2 receptors and PP-1 may interact with spinophilin at distinct sites at the same time, as is
shown in D. Lane numbers in B, C, and D correspond to the fusion proteins diagramed in A.
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assays as described above. The third cytoplasmic loops of both
D2L and D2S exhibit a comparable interaction; both are able to
activate transcription of reporter genes in yeast and both bind
specifically to GST-spinophilin fusion proteins when expressed
in vitro as 35S-labeled proteins (Fig. 5). These data suggest that
the 29-amino acid insert that is unique to the third cytoplasmic
loop of D2L is not responsible for the interaction with spinophi-
lin and that functional differences between the long and short
isoforms are unlikely to arise from differential interactions
with spinophilin.
Although the data above demonstrate that the interaction
between spinophilin and the third cytoplasmic loop of D2L and
D2S seen in the yeast two-hybrid system also occurs as a direct
interaction in vitro, they do not address the issue of an in vivo
interaction. To begin to study this question, we constructed and
expressed an HA-tagged D2S receptor in MDCK cells. MDCK
cells are a cultured kidney epithelial cell line that grow as
confluent monolayers of polarized cells. Previously, Satoh et al.
(11) showed that spinophilin is endogenously expressed in
MDCK cells and is localized to the lateral cell surface, overlap-
ping markers for adherens junctions. We expressed the HA-
tagged receptor in these cells to see whether it would be tar-
geted to the same subcellular domain as spinophilin.
Saturation binding assays with the radioligand [3H]spiperone
indicate the presence of functional ligand-binding sites only in
the cells stably transfected with the HA-D2S construct (data
not shown). Spinophilin was detected in these cells using rabbit
polyclonal antibody NC152, and the receptor was detected us-
ing antibodies against the HA tag (BabCo). Spinophilin is lo-
calized to the lateral surface of MDCK cells (Fig. 6A), as re-
ported by Satoh et al. (11). However, we also detect spinophilin
staining apically in cells grown on Transwell filters, as well as
a considerable amount of punctate intracellular staining (Fig.
6B). HA-D2S dopamine receptors are targeted to the lateral
surface in these cells (Fig. 6), although as the expression level
increases, significant amounts of receptor seem to be produced
and stored in intracellular pools (data not shown). Merged
images of the staining patterns of spinophilin and HA-D2S
through a single optical slice indicate that the subcellular lo-
calization of these two proteins overlaps significantly, although
not completely (data not shown), providing additional evidence
for the interaction described above. Although these data do not
provide direct evidence for an in vivo interaction, they do sug-
gest that spinophilin and D2 receptors are found in the same
membrane domain in polarized cells and that when co-ex-
pressed, they will be well positioned to form the interaction we
observe in vitro. Currently, we are unable to co-immunoprecip-
tate a D2 receptor-spinophilin complex. We speculate that this
interaction may be intricately regulated in vivo and are explor-
ing these possibilities. It will be important in the future to
determine whether the disruption of the spinophilin-D2 recep-
tor interaction has significant effects on downstream signaling
events controlled by these receptors.
Although we have co-localized spinophilin and D2 receptors
in MDCK cells, it has yet to be determined whether these two
molecules associate in neurons. One current hypothesis sug-
gests that the polarity of membrane domains of epithelial cells
FIG. 4. The D2 third cytoplasmic loop specifically interacts with spinophilin but not its closest relative, neurabin. A, alignment of
the region of spinophilin that binds to D2Li3, amino acids 100–371, with the corresponding region of the related protein neurabin (amino acids
101–372), reveals low sequence similarity. There are, however, several clusters of high homology in this region. B, the portions of spinophilin and
neurabin listed above were expressed as GST fusion proteins and tested for interaction with 35S-labeled D2Li3. Only spinophilin was able to bind
to the labeled D2 receptor loop. Lane In, input; lane 1, GST; lane 2, GST-spinophilin (100–371); lane 3, GST-neurabin (101–372); lane 4,
GST-spinophilin (354–494).
FIG. 5. The interaction between both long and short splice
variants of the D2 third cytoplasmic loops with spinophilin was
tested in both yeast two-hybrid and in vitro binding assays. A,
the interaction between D2Li3 or D2Si3 and spinophilin conferred a
strong His1 phenotype in the two-hybrid assay. B, in vitro translated
35S-labeled D2Li3 and D2Si3 bound specifically to GST-spinophilin
(100–767) (lanes 2 and 4) but not to GST alone (lanes 1 and 3).
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mimics that of neurons (28, 29). It is not clear that such a model
holds true in all cases (30). Therefore, it is necessary to look for
an association between D2 receptors and spinophilin in neu-
rons and to begin to probe the functional consequences of this
interaction.
Spinophilin and neurabin seem to be defining members of a
family of single PDZ domain proteins that serve as direct links
to the actin cytoskeleton. These two proteins share little ho-
mology with known proteins outside of the domains mentioned
above but are themselves between 41 and 86% identical (11).
The highest degree of homology is in the PDZ domain and in
the region adjacent to and including the coiled-coil(s). These
similarities again suggest that the two proteins may have
overlapping but distinct functions in vivo. Recently, p70S6 ki-
nase was shown to interact with the PDZ domain of neurabin
through a carboxyl-terminal LRMNLCOOH motif (31). This ki-
nase is responsible for the phosphorylation of the S6 protein
component of the 40 S subunit of ribosomes (32). Phosphoryl-
ation generally occurs in response to mitogenic signals and
results in an increased rate of protein synthesis (31, 32). Spi-
nophilin may provide a link between D2 dopamine receptors
and intracellular mitogenic signaling events dependent on
p70S6 kinase. Indeed, in Chinese hamster ovary cells stably
expressing D2 receptors, dopamine application elicits a wort-
mannin and rapamycin-sensitive activation of p70S6 kinase
(33). This activation is pertussis toxin-sensitive, suggesting
that dopamine stimulation of p70S6 kinase activity proceeds
through Gi/o class G proteins (33).
Alternatively, spinophilin may serve as a scaffolding/adapter
protein for multiple GPCRs. It is possible that spinophilin
plays a central role in coordinating signaling pathways medi-
ated by several different Gi-coupled receptors instead of acting
specifically at a single type of receptor. Thus, a careful exam-
ination of the interactions between spinophilin and various
membrane receptors and cytoplasmic signaling molecules will
greatly aid our understanding of the specificity and diversity of
GPCR signaling.
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